BRCA1 and neoplasm: In addition, the finding that BRCA1 hypermethylation has also been found in benign breast lesions (that can later evolve into cancer) and normal tissues adjacent to the tumor site might suggest a potential use of its epigenetic silencing as an early biomarker of genomic instability [48].